Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.86 USD | -5.74% |
|
-10.19% | +177.06% |
Jun. 19 | Jasper Therapeutics, Inc. Announces Board Changes | CI |
Jun. 14 | Jasper Therapeutics, Inc. Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.06% | 350M | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Credit Suisse Starts Jasper Therapeutics at Outperform with $15 Price Target